Outcome
    Moderate Evidence

    Betaine (TMG) for Liver Protection

    Betaine has plausible mechanisms and small positive trials in fatty liver disease, but results are inconsistent.

    Overview

    Betaine has plausible mechanisms and small positive trials in fatty liver disease, but results are inconsistent.

    Verdict

    Mixed evidence

    How It Works

    Betaine supports hepatic phosphatidylcholine synthesis and VLDL export, and protects hepatocytes as an osmolyte.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Up to 20 g/day was trialled in NASH under medical supervision; 3 g/day for general use
    Expected timeframe
    12+ weeks; histological change was not demonstrated

    Protocol

    supervision
    High doses used in NASH trials should only be taken under a hepatologist's care
    evidence note
    Verdict is mixed - the promising pilot data did not survive a proper randomised trial
    what happened
    Pilot studies reported improved liver histology in non-alcoholic steatohepatitis, but a randomised placebo-controlled trial using high-dose betaine found no significant histological improvement over placebo
    if you still trial it
    3 g/day in divided doses with meals for 12 weeks, with liver enzymes checked at baseline and week 12
    if you have fatty liver
    Weight loss of 7-10% remains the only intervention with consistent histological benefit, and it is substantially more effective than any supplement

    Evidence

    What the studies say

    Pilot studies reported improved liver histology in non-alcoholic steatohepatitis, but a randomised placebo-controlled trial found no significant histological benefit despite reduced steatosis on imaging.

    No studies are yet linked to both Betaine (TMG) and Liver Protection.

    Safety

    Caveats

    The definitive randomised trial was negative - do not use betaine in place of weight loss, alcohol reduction and metabolic management. High doses raise LDL cholesterol, which matters especially in fatty liver where cardiovascular risk is already the leading cause of death. Do not exceed 3 g/day without medical supervision. Fishy body odour and gastrointestinal upset are common at higher doses. Not established in pregnancy or breastfeeding. Liver disease needs monitoring by a clinician.

    Less likely to help if

    People with alcohol-related liver disease who continue drinking, and anyone using it instead of weight loss.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.